AB Science: Masitinib as an Adjunct Therapy for Alzheimer's Disease - Drugs.com MedNews
Links shared publicly online about this topic.
- 353total visits
AB Science: Masitinib as an Adjunct Therapy for Alzheimer's Disease - Drugs.com MedNews
Publication in Alzheimer s Research and Therapy Apr 19, 2011 - AB Science SA (Paris AB)(NYSE Euronext - FR0010557264 - AB), a pharmaceutical company specializin
View full resource at drugs.com
Tags: Alzheimer's Disease, Disease and Condition, Drug, Pharma, disease, Science
Most Recently Shared on April 19, 2011 at 6:12 pm By:
AB Science: Masitinib as an Adjunct Therapy for Alzheimer's Disease: Publication in Alzheimer's Research a... http://bit.ly/hFt32q #drug
Advertisement
